ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 640

Association of Body Weight with Cardiovascular Events in Systemic Lupus Erythematosus

George Stojan1, Homa Timlin2, Hong Fang3, Laurence S. Magder4 and Michelle Petri3, 1Division of Rheumatology, Harvard Medical School- Beth Israel Deaconess Medical Center, Boston, MA, 2West Drayton, United Kingdom, 3Johns Hopkins University School of Medicine, Baltimore, MD, 4Department of Epidemiology and Public Health, University of Maryland, Baltimore, MD

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, Obesity and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: Excessive body mass among healthy subjects carries an increased risk of subsequent cardiovascular (CV) events.  In healthy subjects, the relationship between body mass index (BMI) and total and CV mortality follows a U-shaped curve, with the lowest mortality in overweight (BMI 25.0−29.9 kg/m2) and mildly obese (BMI 30.0−34.9 kg/m2) individuals. Despite a high burden of CV disease in systemic lupus erythematosus (SLE), the relationship between BMI and CV outcomes in SLE has not been studied.

Methods: We estimated the effect of BMI on CV events in a cohort of 2000 patients with SLE. We analyzed the rate of CV events during cohort participation, for five predetermined body weight groups: low (BMI<20 kg/m2), normal weight (reference, BMI 20-24.9 kg/m2), overweight (25-29.9 kg/m2), obese (BMI 30-34.9 kg/m2), and severely obese (BMI>35 kg/m2).  CV events were defined as either stroke, myocardial infarction, incident angina, a coronary procedure (CABG or PCI), or claudication.  Those with a CV event prior to cohort entry were excluded. We adjusted for various confounding factors (age, sex, race, complement, hematocrit, anti-dsDNA, immunosuppressant use), including related CV risk factors: hypertension, hypercholesterolemia, diabetes and smoking.

Results: There were 140 CV events observed over 11,374 person-years of follow-up. The rate of CV events per 1000 patient years of follow up was 6.0 for low weight,  9.3 for normal weight, 14.5 for overweight, 17 for obese, and 13.2 for severely obese. The rate of CV events in obese patients was statistically significantly higher compared to patients with normal weight (p=0.015) in a non adjusted model. After adjusting for confounding factors the p-value approached statistical significance (p=0.062).           

BMI (kg/m2)

Person-years

CV events

Rate1

 

Unadjusted model

Adjusted model

RR

(95% CI)

P-value

RR

(95% CI)

P-value

<20

1006

6

6.0

0.6

(0.3, 1.5)

0.31

0.5

(0.2, 1.3)

0.14

20-24.9

3644

34

9.3

1.0

(REF.GP)

 

1.0

(Ref. Gp)

 

25-29.9

3095

45

14.5

1.6

(1.0, 2.4)

0.051

1.2

(0.7, 1.9)

0.52

30-34.9

1884

32

17.0

1.8

(1.1, 3.0)

0.015

1.6

(0.9, 2.7)

0.078

>35

1744

23

13.2

1.4

(0.8, 2.4)

0.20

1.1

(0.6, 2.0)

0.73

1 Per 1000 person years

Conclusion: Obesity (BMI 30-34.9 kg/m2) is associated with the highest rate of adverse cardiovascular events in SLE. Interestingly, the CV event rate in severe obesity (BMI>35 kg/m2) was lower than in overweight and obese patients, suggesting the presence of a unique obesity paradox in SLE that differs from the one described in the general population.


Disclosure:

G. Stojan,
None;

H. Timlin,
None;

H. Fang,
None;

L. S. Magder,
None;

M. Petri,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-body-weight-with-cardiovascular-events-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology